PFS and correlative biomarker analysis from coBRIM study of cobimetinib plus vemurafenib in advanced BRAF-mutated melanoma | Dr Paolo Ascierto at ASCO 2015

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Paolo A. Ascierto, MD, of Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy, discusses the media... Author: EMJ Added: 07/20/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts